135 related articles for article (PubMed ID: 21234781)
1. A study of six point mutation analysis of LRRK2 gene in Chinese mainland patients with Parkinson's disease.
Hu ZX; Peng DT; Cai M; Pu JL; Lei XG; Yin XZ; Ou-Yang ZY; Luo W; Zhang BR
Neurol Sci; 2011 Aug; 32(4):741-2. PubMed ID: 21234781
[No Abstract] [Full Text] [Related]
2. A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease.
Wang L; Guo JF; Nie LL; Xu Q; Zuo X; Sun QY; Yan XX; Tang BS
Neurosci Lett; 2010 Jan; 468(3):198-201. PubMed ID: 19879329
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
[No Abstract] [Full Text] [Related]
4. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 protein is a component of Lewy bodies.
Zhu X; Siedlak SL; Smith MA; Perry G; Chen SG
Ann Neurol; 2006 Nov; 60(5):617-618. PubMed ID: 16847950
[No Abstract] [Full Text] [Related]
6. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
[TBL] [Abstract][Full Text] [Related]
7. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
Gosal D; Lynch T; Ross OA; Haugarvoll K; Farrer MJ; Gibson JM
Mov Disord; 2007 Jan; 22(2):291-2. PubMed ID: 17089395
[No Abstract] [Full Text] [Related]
8. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.
Deng H; Le W; Guo Y; Hunter CB; Xie W; Jankovic J
Ann Neurol; 2005 Jun; 57(6):933-4. PubMed ID: 15929036
[No Abstract] [Full Text] [Related]
9. A common LRRK2 mutation in idiopathic Parkinson's disease.
Gilks WP; Abou-Sleiman PM; Gandhi S; Jain S; Singleton A; Lees AJ; Shaw K; Bhatia KP; Bonifati V; Quinn NP; Lynch J; Healy DG; Holton JL; Revesz T; Wood NW
Lancet; 2005 Jan 29-Feb 4; 365(9457):415-6. PubMed ID: 15680457
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population.
Chen L; Zhang S; Liu Y; Hong H; Wang H; Zheng Y; Zhou H; Chen J; Xian W; He Y; Li J; Liu Z; Pei Z; Zeng J
Parkinsonism Relat Disord; 2011 May; 17(4):291-2. PubMed ID: 21159540
[No Abstract] [Full Text] [Related]
12. The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.
Schlitter AM; Woitalla D; Mueller T; Epplen JT; Dekomien G
J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):891-2. PubMed ID: 16788020
[No Abstract] [Full Text] [Related]
13. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
Bonifati V
Eur J Hum Genet; 2006 Oct; 14(10):1061-2. PubMed ID: 16835587
[No Abstract] [Full Text] [Related]
14. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
[TBL] [Abstract][Full Text] [Related]
15. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H
Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413
[No Abstract] [Full Text] [Related]
16. Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.
Papapetropoulos S; Argyriou AA; Mitsi G; Chroni E
Eur J Neurol; 2007 Nov; 14(11):e6. PubMed ID: 17956439
[No Abstract] [Full Text] [Related]
17. LRRK2 G2019S founder haplotype in the Chinese population.
Tan EK; Skipper L; Tan L; Liu JJ
Mov Disord; 2007 Jan; 22(1):105-7. PubMed ID: 17083102
[TBL] [Abstract][Full Text] [Related]
18. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
[TBL] [Abstract][Full Text] [Related]
19. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
[TBL] [Abstract][Full Text] [Related]
20. The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.
Guo R; Hu X; Chen Q; Zhang Y; Zhang Y; Sun Y; Hu G
Genet Test Mol Biomarkers; 2013 Feb; 17(2):131-4. PubMed ID: 23268655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
